epinastine and zafirlukast share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.150 means 15% of the combined target set is bound by both compounds. The IDF-weighted score of 0.159 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do epinastine and zafirlukast have in common?
epinastine and zafirlukast share 3 molecular targets with a Jaccard similarity of 15%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can epinastine and zafirlukast be combined?
epinastine and zafirlukast share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: epinastine or zafirlukast?
In the BiohacksAI corpus: epinastine has 0 PubMed-indexed studies, zafirlukast has 0 studies.